维普期刊资源整合服务平台（V6.5）

150篇 您的检索式：作者名="Marzocchi"

选中清除导出查看参考文献查看引证文献引用追踪共8页首页上一页第1页下一页末页 /8 跳转

	题名	作者	年代	出处	被引量
1	The Role of Lifestyle Change in the Prevention and Treatment of NAFLD显示文摘	Elena Centis Rebecca Marzocchi Alessandro Suppini Riccardo Dalle Grave Nicola Villanova Ingrid J Hickman Giulio Marchesini	2013	Current Pharmaceutical Design2013，，29：	2
2	Nonalcoholic fatty liver disease and the metabolic syndrome显示文摘	Marchesini G Marzocchi R Agostini F	2005	Curr Opin Lipidol2005，16，4：	1
3	Long-term effectiveness of early administration of glycoprotein lIb/IIIa agents to real-world patients undergoing primary percutaneous interventions: re- sults of a registry study in an ST-elevation myocardial infarction network显示文摘	ORTOLANI P MARZOCCHI A MARROZZINI C	2009	Eur Heart J2009，30，：	1
4	Executive function profiles of children with attention deficit hyperactivity disorder显示文摘	SHALLCE T I M MARZOCCHI G M COSER S	2002	Developmental Neurochopsychology2002，21，1：	1
5	药物洗脱支架应用的长期安全性和有效性:REAL多中心注册研究的两年结果显示文摘背景:药物洗脱支架(DES)应用的长期安全性和有效性近来受到质疑。方法和结果:在2002年7月至2005年6月间,10629例应用DES(n=3064)或裸金属支架(BMS;n=7565)行择期经皮冠状动脉介入治疗的患者被纳入一项前瞻性注册研究(包括13所医院)。	Marzocchi A. Saia F. Piovaccari G. 刘相飞	2007	世界核心医学期刊文摘(心脏病学分册)2007，，11：	1
6	Nonal coholic fatty liver disease and the metabolic syndrome显示文摘	Marchesini G Marzocchi R Agostini F	2005	CurrOpin Lipidol2005，16，4：	1
7	Comparison between coronary angioplasty and coronary artery bypass surgery for the treatment of unprotected left main coronary artery stenosis ( the Bologna Registry) 显示文摘	Palmerini T Marzocchi A Marrozzini C	2006	Am J Cardiol2006，98，：	1
8	Long-term safetyand efficacy of drug-eluting stents:two-year results of theREAL (Registro AngiopLastiche dell'Emilia Romagna) multicenterregistry显示文摘	Marzocchi A Saia F Piovaccari G	2007	Circulation2007，115，25：	1
9	Branchedchain amino acid supplementation in patients with liver diseases显示文摘	Marchesini G Marzocchi R Noia M	2005	J Nutr2005，135，6：	1
10	A critical point theory for nonsmooth functionals显示文摘	Degiovanni M Marzocchi M		0，，04：	1
11	Nonalcoholic fatty liver disease and the metabolic syndrome 显示文摘	Marchesini G Marzocchi R Agostini F	2005	Curr Opin Lipidol2005，16，5：	1
12	Randomized comparison hetween tirofiban and abciximab to promote complete ST resolution in primary angioplasty: results of the faeilitated angioplasty with tirofiban or abeiximab (FATA) in ST-elevation myocardial infarction trial显示文摘	Marzocchi A Manari A Piovaccari G	2008	Eur Heart J2008，29，24：	1
13	Basic principles of multi-riskassessment: a case study in Italy显示文摘	MARZOCCHI W GARCIA-ARISTIZABAL A GASPARINI P	2012	Natural Hazards2012，62，2：	1
14	Nonalcoholic fatty liver disease and the metabolic syndrome显示文摘	Marchesini G Marzocchi R Agostini F	2005	Curr Opin Lipidol2005，16，4：	1
15	Randomized comparison between tirofiban and abciximab to promote corn plete ST resolution in primary angioplasty: results of the facilitated angioplasty with tirofiban or abciximab (FATA) in ST-elevation myocardial infarction trial显示文摘	Marzocchi A Manari A Piovaccari G	2008	Eur Heart J2008，29，24：	1
16	Nonaleoholic fatty liver disease and the Metabolic syndrome显示文摘	MARCHESINI G MARZOCCHI R AGOSTINI F	2005	CurrOPin Lipidol2005，16，4：	1
17	Nonalcoholic fatty liver disease and the metabolic syndrome显示文摘	Marchesini G Marzocchi R Agostini F	2005	Curr Opin Lipidol2005，16，4：	1
18	Nonalcoholic fatty liver disease and the metabolic syndrome 显示文摘	Marchesini G Marzocchi R Agostini F	2005	Curr Opin Lipidol2005，16，：	1
19	J Am Chem Soc显示文摘	Zanarini S Rampazzo E Ciana L D Marcaccio M Marzocchi E Montalti M Paolucci F Prodi L	2009	131:22602009，131，：	1
20	Preprocedura levels of C-reactive protein and leukocyte counts predict 9-month mortality after coronary angioplasty for the treatment of unprotected left main coronary artery stenosis 显示文摘	Palmerini T Marzocchi A Marrozzin C	2005	Circulation2005，112，3：	1

返回顶部每页显示：

共8页首页上一页第1页下一页末页 /8 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示